Related references
Note: Only part of the references are listed.Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study
Preeti Shashi et al.
GASTROENTEROLOGY REPORT (2020)
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience
Uri Kopylov et al.
DIGESTIVE AND LIVER DISEASE (2019)
Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
Nienke Z. Borren et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study
Tomer Adar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease
Udayakumar Navaneethan et al.
INFLAMMATORY BOWEL DISEASES (2017)
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience
Uri Kopylov et al.
INFLAMMATORY BOWEL DISEASES (2017)
Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
Nabeel Khan et al.
DRUGS & AGING (2017)
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age
Vijay Yajnik et al.
ADVANCES IN THERAPY (2017)
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Cloe Charpentier et al.
GUT (2014)
Share Paper
